Literature DB >> 21222592

Cognition and neuropathology in aging: multidimensional perspectives from the Rush Religious Orders Study and Rush Memory And Aging Project.

S Negash1, D A Bennett, R S Wilson, J A Schneider, S E Arnold.   

Abstract

It is increasingly recognized that the correlation between neuropathological lesions and cognition is modest and accounts for about a quarter of the variance of cognition among older adults. Some individuals maintain normal cognitive functioning amidst significant brain pathology, while others suffer varying degrees of cognitive and neurological deterioration that render them dependent and frail. We present data from the Religious Orders Study and the Memory and Aging Project pertaining to pathology and cognition, and propose a paradigm shift in consideration of the neurobiology of healthy aging and dementia. Factors that modify or mediate the association between neuropathology and cognition are also discussed. It is hypothesized that the concept of resilient aging can serve as a useful entity in understanding mechanisms that underlie healthy aging amidst disease-related pathology.

Entities:  

Mesh:

Year:  2011        PMID: 21222592      PMCID: PMC3157574          DOI: 10.2174/156720511795745302

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  48 in total

Review 1.  What is cognitive reserve? Theory and research application of the reserve concept.

Authors:  Yaakov Stern
Journal:  J Int Neuropsychol Soc       Date:  2002-03       Impact factor: 2.892

2.  Neuropathologic studies of the Baltimore Longitudinal Study of Aging (BLSA).

Authors:  Richard J O'Brien; Susan M Resnick; Alan B Zonderman; Luigi Ferrucci; Barbara J Crain; Olga Pletnikova; Gay Rudow; Diego Iacono; Miguel A Riudavets; Ira Driscoll; Donald L Price; Lee J Martin; Juan C Troncoso
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

3.  Brain lesions at autopsy in older Japanese-American men as related to cognitive impairment and dementia in the final years of life: a summary report from the Honolulu-Asia aging study.

Authors:  Lon White
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

4.  Participation in cognitively stimulating activities and risk of incident Alzheimer disease.

Authors:  Robert S Wilson; Carlos F Mendes De Leon; Lisa L Barnes; Julie A Schneider; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  JAMA       Date:  2002-02-13       Impact factor: 56.272

5.  Distinguishing between neurodegenerative disease and disease-free aging: correlating neuropsychological evaluations and neuropathological studies in centenarians.

Authors:  Margery H Silver; Kathy Newell; Christopher Brady; E Tessa Hedley-White; Thomas T Perls
Journal:  Psychosom Med       Date:  2002 May-Jun       Impact factor: 4.312

6.  Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.

Authors:  M N Sabbagh; K Cooper; J DeLange; J D Stoehr; K Thind; T Lahti; B Reisberg; L Sue; L Vedders; S R Fleming; T G Beach
Journal:  Curr Alzheimer Res       Date:  2010-06       Impact factor: 3.498

7.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

8.  Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer's disease.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; N T Aggarwal; S E Arnold; E J Cochran; E Berry-Kravis; J L Bienias
Journal:  Neurology       Date:  2003-01-28       Impact factor: 9.910

9.  The neuropathology of older persons with and without dementia from community versus clinic cohorts.

Authors:  Julie A Schneider; Neelum T Aggarwal; Lisa Barnes; Patricia Boyle; David A Bennett
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  The neuropathology of probable Alzheimer disease and mild cognitive impairment.

Authors:  Julie A Schneider; Zoe Arvanitakis; Sue E Leurgans; David A Bennett
Journal:  Ann Neurol       Date:  2009-08       Impact factor: 10.422

View more
  38 in total

1.  Beta amyloid, tau, neuroimaging, and cognition: sequence modeling of biomarkers for Alzheimer's Disease.

Authors:  S Duke Han; Jonathan Gruhl; Laurel Beckett; Hiroko H Dodge; Nikki H Stricker; Sarah Farias; Dan Mungas
Journal:  Brain Imaging Behav       Date:  2012-12       Impact factor: 3.978

2.  Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure.

Authors:  Katherine A Gifford; Dandan Liu; Jacquelyn E Neal; Lealani Mae Y Acosta; Susan P Bell; Margaret E Wiggins; Kristi M Wisniewski; Mary Godfrey; Laura A Logan; Timothy J Hohman; Kimberly R Pechman; David J Libon; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Assessment       Date:  2018-05-29

Review 3.  Vascular disease and dementias: paradigm shifts to drive research in new directions.

Authors:  Mitchel A Kling; John Q Trojanowski; David A Wolk; Virginia M Y Lee; Steven E Arnold
Journal:  Alzheimers Dement       Date:  2012-11-22       Impact factor: 21.566

4.  Overview and findings from the religious orders study.

Authors:  David A Bennett; Julie A Schneider; Zoe Arvanitakis; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

5.  Overview and findings from the rush Memory and Aging Project.

Authors:  David A Bennett; Julie A Schneider; Aron S Buchman; Lisa L Barnes; Patricia A Boyle; Robert S Wilson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

6.  Pharmacological Rescue of Long-Term Potentiation in Alzheimer Diseased Synapses.

Authors:  G Aleph Prieto; Brian H Trieu; Cindy T Dang; Tina Bilousova; Karen H Gylys; Nicole C Berchtold; Gary Lynch; Carl W Cotman
Journal:  J Neurosci       Date:  2016-12-16       Impact factor: 6.167

7.  Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span.

Authors:  Ge Li; Steven P Millard; Elaine R Peskind; Jing Zhang; Chang-En Yu; James B Leverenz; Cynthia Mayer; Jane S Shofer; Murray A Raskind; Joseph F Quinn; Douglas R Galasko; Thomas J Montine
Journal:  JAMA Neurol       Date:  2014-06       Impact factor: 18.302

8.  Brain Injury and Later-Life Cognitive Impairment and Neuropathology: The Honolulu-Asia Aging Study.

Authors:  E Julia Chosy; Noele Gross; Marnie Meyer; Catherine Y Liu; Steven D Edland; Lenore J Launer; Lon R White
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 9.  Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

Authors:  Fernanda G De Felice
Journal:  J Clin Invest       Date:  2013-02-01       Impact factor: 14.808

10.  Synapse stability in the precuneus early in the progression of Alzheimer's disease.

Authors:  Stephen W Scheff; Douglas A Price; Frederick A Schmitt; Kelly N Roberts; Milos D Ikonomovic; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.